drugset
drugset / Trial / NCT04811053

HR021618 in Moderate to Severe Pain After Abdominal Surgery

NCT04811053 ↗

Phase 2 Completed 60 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the efficacy and safety of HR021618 in the treatment of moderate to severe pain after abdominal surgery.

Timeline

Start
2021-04-12
Primary completion
2021-07-15
Completion
2021-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject HR021618 Unknown — —

Indications

No indication recorded.